A Pilot Study of a Mindfulness-Based Stress Reduction Programme in Patients Suffering from Atopic Dermatitis
Martin Offenbächer, Michael Seitlinger, Daniela Münch, Christina Schnopp, Ulf Darsow, Julia Harfensteller, Peter Schmid-Grendelmeier, Johannes Ring, Niko Kohls
Psych December 23, 2021 DOI: 10.3390/psych3040042 (opens in new tab) via DOAJ
Summary
AI-generated from the abstractA pilot study tested an 8-week Mindfulness-Based Stress Reduction (MBSR) programme in 10 adults with atopic dermatitis (mean age 53 years, mean disease duration 36.6 years). The programme was feasible and acceptable. Pre-post comparisons showed significant improvement on the Freiburg Mindfulness Inventory subscales of presence and acceptance, and a trend toward reduced perceived stress, which participants' qualitative feedback supported. The authors suggest MBSR may be a promising adjunct to conventional treatment for atopic dermatitis.
Study at a glance
| Characteristics | Pilot study Qualitative Peer reviewed |
|---|---|
| Sample size | 10 |
| Population | Adult patients with atopic dermatitis |
| Intervention | Mindfulness-Based Stress Reduction (MBSR) programme |
| Duration | 8-week intervention |
| Keywords | Atopic dermatitis Mindfulness stress reduction Psychosomatic interactions Eczema |
| Key finding | The MBSR programme significantly improved mindfulness (presence and acceptance subscales) and showed a trend toward reduced stress in atopic dermatitis patients. |
Abstract
Introduction: Patients with atopic dermatitis (AD) have several potential stressors including the symptoms of the disease itself, the stigmatization due to their appearance, and emotional and psychological strain. Psychological factors and stress can trigger and exacerbate the symptoms of skin diseases and there is evidence that stress has a relevant clinical effect on the function of skin cells in vivo. Our objective was to evaluate in a pilot study the feasibility, acceptance, and effectiveness of a Mindfulness-Based Stress Reduction (MBSR) programme in AD patients in a clinical setting. Methods: 10 patients took part in an 8-week MBSR programme, which included, e.g., mindful and conscious awareness of the body and bodywork, and seated meditation. We assessed sociodemographics and disease related variables with standardized measures at predefined time points including Score of Atopic Dermatitis, Patient Oriented Eczema Measure, Dermatology Life Quality Index, Perceived Stress Questionnaire, Freiburg Mindfulness Inventory (FMI), and others. Participants also gave qualitative feedback regarding the effects of the intervention. Results: The mean age was 53.10 years (SD = 15.04), seven patients were female, and disease duration was 36.6 years (SD = 25.5). Calculating pre-post effect sizes (Cohen’s d), the FMI indicated significant improvement in the “presence” and “acceptance” subscales. There was also tendency for less stress. This was confirmed by the qualitative statements of the participants. Conclusions: The MBSR programme is feasible and acceptable for AD patients. Considering the long disease history and the severity of disease burden, the effects of this intervention seem promising as an adjunct to conventional treatments for patients with AD.